Our research projects

Looking at why ALCL sometimes relapses with a new targeted treatment, and understanding how to optimise this treatment approach.

Developing a new dye to make kidney cancer surgery safer and more effective.

Improving genetic testing for children with kidney cancers like Wilms tumour and finding a way to improve diagnosis and relapse monitoring.

Investigating how different levels short non-coding RNAs affect germ cell tumour cells, and testing whether medicines altering these levels could be a potential treatment.

Investigating whether diet or lifestyle changes could help children cope with bone marrow transplants better.

Looking at whether a pre-existing drug could be an effective and safe treatment due to its ability to target cancer cells directly.

Dr Jess Morgan at Leeds Children’s Hospital and Dr Gemma Bryan at University of Surrey hope to understand more about how hospitals are offering chemotherapy that needs to be given as infusions over a number of days.

Looking for repurposed treatments that can fight leukaemia cells in very young children.

Creating a new immunotherapy that will attacks collagen in cancer cells, and testing whether it is effective in model systems to make it the best it can be.